CClinicalTrials.gg
WithdrawnNCT04359433Updated May 14, 2024

Intermittent Exercise Among Students

An interventional study of Exercise programme in Cardiometabolic Risk, sponsored by Children's Hospital of Fudan University. Withdrawn at 1 site in China. Open to participants aged 6 Years to 18 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-05-14.

Sponsored by Children's Hospital of Fudan University · Not applicable, Interventional, and Supportive care

Why this study was withdrawn
Funding issue
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
6 Years to 18 Years
Sex
All
01

Study summary

Evaluate the effectiveness of intermittency anaerobic exercise interventions among the students with high risk of cardiometabolic .

02

Conditions studied

  • Cardiometabolic Risk

Keywords

  • cardiometabolic
  • children
  • Waist to height ratio, WHtR
  • Intermittent Anaerobic Exercise
03

In context

Lead sponsor

Children's Hospital of Fudan University is the lead sponsor of 262 studies on the registry; 92 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
6 Years to 18 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Male: Waist-to-height ratio≥0.463
  • Female: Waist-to-height ratio≥0.469
  • Students with cardiometabolic risk factors include elevated BP, dyslipidaemia, elevated fasting blood glucose (FBG) and central obesity.

Exclusion criteria

Exclusion Criterias:

  • Participates with severe disease conditions include cardiac insufficiency, respiratory system relate diseases, immunodeficiency or severe malnutrition, ect
  • Taking or having taken weight-loss drugs
  • Participates unsuitable or improper to participate the study
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Standard group

    The participates in this group would provide normal health education of scientific and rational diet.

  • Experimental
    Exercise intervention group

    Besides normal health education of scientific and rational diet,the participates in this group would be suggested to carry out an anaerobic exercise named Tabata.

    Behavioral: Exercise programme

Interventions

  • BehavioralExercise programme

    Exercise programme includes 8 anaerobic movements choosen from Tabata. This exercise programme workout is aimed at body fat reduction, and the structure is as follows: * 8 anerobic movements in 20 seconds is a set * Rest for 10 seconds before another set * Finish 4 sets every time, it shall take you 4 minutes * Do 4 sets 2 to 3 times a week

06

What researchers measure

Primary outcomes

  1. Abnormal of cardiometabolic risk related index

    Cardiometabolic risk related index includes fasting blood glucose, blood lipids, blood pressure and abdominal obesity.Cardiometabolic risk related index would be set to 1 as at least 2 indexs mentioned were abnormal while 0 for less than 2.

    Time frame: 3th month after enrollment

Secondary outcomes

  1. Change of Waist-to-height ratio

    Waist-to-height ratio is calculated by the formula :Waist-to-height ratio=waistline (cm)/height(cm). All the participates' Waist-to-height ratio would be calculated at baseline and 12th months after enrollment. The change would be manifested in the situatuion of the difference.

    Time frame: Baseline, 12th months after enrollment

  2. Change of Body Mass Index

    Body Mass Index is calculated by the formula :Body Mass Index=weight(kg)/(height(cm))\^2. All the participates' Body Mass Index would be calculated at baseline and 12th months after enrollment. The change would be manifested in the situatuion of the difference.

    Time frame: Baseline, 12th months after enrollment

  3. Change of hipline

    All the participates' hipline would be measured at baseline and 12th months after enrollment. The change would be manifested in the situatuion of the difference.

    Time frame: Baseline, 12th months after enrollment

07

Study locations

1 site
  • Children's Hospital of Fudan University
    Shanghai, China
08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 14, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04359433
Lead sponsor
Children's Hospital of Fudan University
Responsible party
Sponsor
First posted
Apr 24, 2020
Start date
Aug 2, 2021
Primary completion
Sep 2024 (estimated)
Completion
Dec 2024 (estimated)
Last update
May 14, 2024

Study contacts

Weili Yan, PhD
study chair · Children's Hospital of Fudan University

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in May 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion